Properties
Description
BCR-ABL-IN-2 specifically inhibits the activity of the Bcr-Abl tyrosine kinase.
Molecular Formula
C24H25Cl2N5O3
Identity
Confirmed by NMR/HPLC/MS.
Applications
BCR-ABL-IN-2 aids in elucidating mechanisms of resistance to standard CML therapies and potential combinatory treatment approaches.